Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteria.

Autor: Murphy M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Suliman S; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Briel L; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Veldtsman H; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Khomba N; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Africa H; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Steyn M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Snyders CI; Department of Science and Technology, National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., van Rensburg IC; Department of Science and Technology, National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Walzl G; Department of Science and Technology, National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Chegou NN; Department of Science and Technology, National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Hanekom WA; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa., Nemes E; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Cape Town, South Africa. Electronic address: elisa.nemes@uct.ac.za.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 May; Vol. 130 Suppl 1, pp. S52-S62. Date of Electronic Publication: 2023 Feb 25.

Impact of perinatal factors on T cells and transcriptomic changes in preterm infant brain injury.

Autor: Zhang, Xiaoli¹ (AUTHOR), Yang, Yu¹ (AUTHOR), Xu, Yiran¹ (AUTHOR), Chen, Liuji¹ (AUTHOR), Niu, Ming¹ (AUTHOR), Zhu, Jinjin¹ (AUTHOR), Zhang, Shan¹ (AUTHOR), Wu, Yanan¹ (AUTHOR), Li, Bingbing¹ (AUTHOR), Zhang, Lingling¹ (AUTHOR), Song, Juan¹ (AUTHOR), Xu, Falin¹ (AUTHOR), Bi, Dan² (AUTHOR), Zhao, Xin³ (AUTHOR), Zhu, Changlian^1,4 (AUTHOR) changlian.zhu@neuro.gu.se, Wang, Xiaoyang^1,5 (AUTHOR) xiaoyang.wang@fysiologi.gu.se

Publikováno v: Journal of Neuroinflammation. 11/29/2024, Vol. 21 Issue 1, p1-11. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy.

Autor: Cazzetta, Valentina^1,2 (AUTHOR), Depierreux, Delphine^3,4,5 (AUTHOR), Colucci, Francesco^3,4 (AUTHOR), Mikulak, Joanna¹ (AUTHOR) joanna.mikulak@humanitasresearch.it, Mavilio, Domenico^1,2 (AUTHOR) joanna.mikulak@humanitasresearch.it

Publikováno v: Cancers. Feb2023, Vol. 15 Issue 4, p1264. 21p.

Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis.

Autor: Sankar, Poornima, Mishra, Bibhuti Bhusan

Publikováno v: Frontiers in Immunology; 2023, p1-21, 21p